Alzinova Toekomstige groei
Future criteriumcontroles 0/6
Alzinova's revenue and earnings are forecast to decline at 79.1% and 67.3% per annum respectively while EPS is expected to decline by 55.1% per annum.
Belangrijke informatie
-67.3%
Groei van de winst
-55.1%
Groei van de winst per aandeel
Biotechs winstgroei | 48.4% |
Inkomstengroei | -79.1% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 28 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | N/A | -60 | -84 | -84 | 2 |
12/31/2025 | N/A | -57 | -62 | -55 | 2 |
12/31/2024 | 56 | 15 | 12 | 18 | 2 |
6/30/2024 | 15 | -18 | -32 | -17 | N/A |
3/31/2024 | 18 | -17 | -34 | -17 | N/A |
12/31/2023 | 20 | -16 | -35 | -15 | N/A |
9/30/2023 | 17 | -16 | -31 | -13 | N/A |
6/30/2023 | 17 | -16 | -32 | -15 | N/A |
3/31/2023 | 14 | -15 | -32 | -17 | N/A |
12/31/2022 | 17 | -13 | -27 | -10 | N/A |
9/30/2022 | 16 | -11 | -26 | -10 | N/A |
6/30/2022 | 15 | -9 | -27 | -12 | N/A |
3/31/2022 | 17 | -8 | -25 | -8 | N/A |
12/31/2021 | 17 | -8 | -27 | -10 | N/A |
9/30/2021 | 18 | -7 | -25 | -7 | N/A |
6/30/2021 | 19 | -7 | -24 | -5 | N/A |
3/31/2021 | 16 | -6 | -20 | -5 | N/A |
12/31/2020 | 15 | -6 | -21 | -6 | N/A |
9/30/2020 | 13 | -7 | -21 | -8 | N/A |
6/30/2020 | 12 | -6 | -18 | -7 | N/A |
3/31/2020 | 11 | -7 | -17 | -6 | N/A |
12/31/2019 | 7 | -6 | -11 | -4 | N/A |
9/30/2019 | 5 | -5 | -11 | -6 | N/A |
6/30/2019 | 6 | -5 | -11 | -5 | N/A |
3/31/2019 | 8 | -5 | -11 | -3 | N/A |
12/31/2018 | 9 | -4 | -13 | -4 | N/A |
9/30/2018 | 11 | -3 | -13 | -2 | N/A |
6/30/2018 | 10 | -3 | -11 | -2 | N/A |
3/31/2018 | 8 | -2 | N/A | -2 | N/A |
12/31/2017 | 6 | -3 | N/A | -2 | N/A |
9/30/2017 | 5 | -3 | N/A | -2 | N/A |
6/30/2017 | 4 | -3 | N/A | -3 | N/A |
3/31/2017 | 5 | -4 | N/A | -3 | N/A |
12/31/2016 | 5 | -3 | N/A | -3 | N/A |
9/30/2016 | 5 | -4 | N/A | -3 | N/A |
6/30/2016 | 4 | -4 | N/A | -3 | N/A |
3/31/2016 | 2 | -3 | N/A | -3 | N/A |
12/31/2015 | 1 | -3 | N/A | -3 | N/A |
12/31/2014 | 1 | 0 | N/A | -1 | N/A |
12/31/2013 | 1 | 0 | N/A | N/A | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: ALZ is forecast to remain unprofitable over the next 3 years.
Winst versus markt: ALZ is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: ALZ is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: ALZ's revenue is expected to decline over the next 3 years (-79.1% per year).
Hoge groei-inkomsten: ALZ's revenue is forecast to decline over the next 3 years (-79.1% per year).
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if ALZ's Return on Equity is forecast to be high in 3 years time